283 related articles for article (PubMed ID: 29636302)
21. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
22. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma: Percutaneous biliary drainage has no adverse effects on survival.
Zhang XF; Beal EW; Merath K; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
J Surg Oncol; 2018 May; 117(6):1267-1277. PubMed ID: 29205351
[TBL] [Abstract][Full Text] [Related]
23. Dynamic Change of Total Bilirubin after Portal Vein Embolization is Predictive of Major Complications and Posthepatectomy Mortality in Patients with Hilar Cholangiocarcinoma.
Ou Yang Q; Zhang S; Cheng QB; Li B; Feng FL; Yu Y; Luo XJ; Lin ZF; Jiang XQ
J Gastrointest Surg; 2016 May; 20(5):960-9. PubMed ID: 26831059
[TBL] [Abstract][Full Text] [Related]
24. Clinical presentation, diagnosis, and survival in cholangiocarcinoma: A prospective study.
Vasilieva L; Papadhimitriou SI; Alexopoulou A; Kostopoulos I; Papiris K; Pavlidis D; Xinopoulos D; Romanos A; Dourakis SP
Arab J Gastroenterol; 2016 Dec; 17(4):181-184. PubMed ID: 27914884
[TBL] [Abstract][Full Text] [Related]
25. Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.
Dekker AM; Wiggers JK; Coelen RJ; van Golen RF; Besselink MG; Busch OR; Verheij J; Hollmann MW; van Gulik TM
HPB (Oxford); 2016 Mar; 18(3):262-70. PubMed ID: 27017166
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
27. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.
Su CH; Tsay SH; Wu CC; Shyr YM; King KL; Lee CH; Lui WY; Liu TJ; P'eng FK
Ann Surg; 1996 Apr; 223(4):384-94. PubMed ID: 8633917
[TBL] [Abstract][Full Text] [Related]
28. Surgical Strategies for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma: Bile Duct Resection with or Without Hepatectomy?
Chen RX; Li CX; Luo CH; Zhang H; Zhou T; Wu XF; Wang XH; Li XC
Ann Surg Oncol; 2020 Sep; 27(9):3374-3382. PubMed ID: 32274664
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.
Sun Q; Li F; Sun F; Niu J
Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407
[TBL] [Abstract][Full Text] [Related]
30. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center.
Ercolani G; Zanello M; Grazi GL; Cescon M; Ravaioli M; Del Gaudio M; Vetrone G; Cucchetti A; Brandi G; Ramacciato G; Pinna AD
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):329-37. PubMed ID: 20464563
[TBL] [Abstract][Full Text] [Related]
31. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
[TBL] [Abstract][Full Text] [Related]
32. Transparenchymal glissonean approach: a novel surgical technique for advanced perihilar bile duct cancer.
Kamachi H; Kamiyama T; Tsuruga Y; Orimo T; Wakayama K; Shimada S; Kakisaka T; Yokoo H; Yamashita K; Taketomi A
Langenbecks Arch Surg; 2018 May; 403(3):387-394. PubMed ID: 29063245
[TBL] [Abstract][Full Text] [Related]
33. Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.
Higuchi R; Yazawa T; Uemura S; Izumo W; Ota T; Kiyohara K; Furukawa T; Egawa H; Yamamoto M
J Gastrointest Surg; 2019 Jul; 23(7):1443-1453. PubMed ID: 30203230
[TBL] [Abstract][Full Text] [Related]
34. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.
Zhang JZ; Yang CX; Gao S; Bu JF; Li QQ; Wang HL; Yang KN; Tong SS; Qian LJ; Zhang J; Hua R; Sun YW; Yan JY; Chen W
World J Surg Oncol; 2023 Aug; 21(1):239. PubMed ID: 37542314
[TBL] [Abstract][Full Text] [Related]
35. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
[TBL] [Abstract][Full Text] [Related]
36. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma.
Chauhan A; House MG; Pitt HA; Nakeeb A; Howard TJ; Zyromski NJ; Schmidt CM; Ball CG; Lillemoe KD
HPB (Oxford); 2011 Feb; 13(2):139-47. PubMed ID: 21241432
[TBL] [Abstract][Full Text] [Related]
37. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma.
Haga Y; Miyamoto A; Wada Y; Takami Y; Takeuchi H
HPB (Oxford); 2016 Mar; 18(3):271-8. PubMed ID: 27017167
[TBL] [Abstract][Full Text] [Related]
38. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
39. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China.
Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY
Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740
[TBL] [Abstract][Full Text] [Related]
40. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
